A growing appreciation of the pathophysiological interrelatedness of metabolic risk factors
such as obesity and diabetes, chronic kidney disease, and cardiovascular disease has led …

Natriuretic peptide [NP; B‐type NP (BNP), N‐terminal proBNP (NT‐proBNP), and
midregional proANP (MR‐proANP)] concentrations are quantitative plasma biomarkers for …

Níveis de evidência Nível A Dados obtidos a partir de múltiplos estudos randomizados de
bom porte, concordantes e/ou de meta-análise robusta de estudos clínicos randomizados …

Level of evidence Level A Data obtained from multiple concordant large randomized trials
and/or robust meta-analysis of randomized clinical trials Level B Data obtained from less …

Background Guidelines for primary prevention of cardiovascular diseases focus on
prediction of coronary heart disease and stroke. We assessed whether or not measurement …

The ideal pathway of care for heart failure patients is a key feature of this consensus
document. It offers a pathway of care that is the foundation from which to assess barriers that …

Normal brain natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) levels are
helpful in excluding chronic heart failure in the ambulatory setting, although they have been …

Aims To evaluate the performance of the WATCH‐DM risk score, a clinical risk score for
heart failure (HF), in patients with dysglycaemia and in combination with natriuretic peptides …

Aims Multivariable prediction models can be used to estimate risk of incident heart failure
(HF) in the general population. A systematic review and meta‐analysis was performed to …

Background Evidence on the economic impact of heart failure (HF) is vital in order to predict
the cost-effectiveness of novel interventions. We estimate the health system costs of HF …